CalciMedica is trading 15.61% up in after-hours trading at $2.29 after a $1.98 close on September 16, 2026, without a clear company-specific catalyst.

  • Latest listed announcement: participation in H.C. Wainwright conference on September 15; investor-relations page shows no September 16 earnings, FDA decision, financing, trial, or other major release.
  • Broader markets were mixed to weaker following the Federal Reserve’s rate hike; macro conditions do not clearly explain the surge. Confidence is low pending a possible delayed filing or announcement.